Escherichia coli fimbria

Escherichia coli fimbriae are long, filamentous structures composed of protein subunits (pilins) that extend from the bacterial surface and mediate specific attachment of E. coli to host cell receptors, primarily via interactions with carbohydrate moieties like mannose or galactose on glycoproteins and glycolipids[1][3][5][7]. This attachment is essential for colonization of host tissues, including the urinary tract, intestinal mucosa, and other surfaces, and is considered a critical early event in the pathogenesis of infections such as urinary tract infections and diarrheal diseases[6][8]. Distinct classes and types of fimbriae (such as Type 1 fimbriae, P fimbriae, and CFA/I fimbriae) vary in receptor specificity and tissue tropism, but all share a common principle of mediating adhesion and initiating infection[2][6][7]. Major subunits make up the shaft of the fimbria, with minor (often adhesive) subunits forming the tip, conferring binding specificity[4]. The force-dependent adhesion of fimbrial adhesins (e.g., FimH) can be reinforced under physiological shear, enhancing bacterial retention against washing forces in the environment[3][8]. Drugs or vaccines that block fimbrial-mediated attachment, particularly by targeting tip adhesins like FimH, are being developed to prevent or treat infections, but no such therapeutic is currently in routine use.

Other names

FimbriaepiliE. coli fimbriaeadhesive fimbriaecolonization factor antigen (e.g., CFA/I)aggregative adherence fimbriae (AAF)Type 1 piliP-pili

Inhibition of fimbrial adhesin binding (e.g., FimH antagonism prevents E. coli binding to mannose on host epithelial cells)\n- Blockade of bacterial colonization/adhesion